Cargando…
High flow nasal oxygen for acute type two respiratory failure: a systematic review
Background: Acute type two respiratory failure (AT2RF) is characterized by high carbon dioxide levels (PaCO (2 )>6kPa). Non-invasive ventilation (NIV), the current standard of care, has a high failure rate. High flow nasal therapy (HFNT) has potential additional benefits such as CO (2) clearance,...
Autores principales: | Alnajada, Asem Abdulaziz, Blackwood, Bronagh, Mobrad, Abdulmajeed, Akhtar, Adeel, Pavlov, Ivan, Shyamsundar, Murali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453312/ https://www.ncbi.nlm.nih.gov/pubmed/34621510 http://dx.doi.org/10.12688/f1000research.52885.2 |
Ejemplares similares
-
High-flow nasal cannula therapy for initial oxygen administration in acute hypercapnic respiratory failure: study protocol of randomised controlled unblinded trial
por: Alnajada, Asem, et al.
Publicado: (2021) -
International Survey of High-Flow Nasal Therapy Use for Respiratory Failure in Adult Patients
por: Alnajada, Asem, et al.
Publicado: (2023) -
Awake Prone Positioning, High-Flow Nasal Oxygen and Non-Invasive Ventilation as Non-Invasive Respiratory Strategies in COVID-19 Acute Respiratory Failure: A Systematic Review and Meta-Analysis
por: Schmid, Benedikt, et al.
Publicado: (2022) -
Use of nasal high flow oxygen during acute respiratory failure
por: Ricard, Jean-Damien, et al.
Publicado: (2020) -
Nasal high-flow therapy for type II respiratory failure in COPD: A report of four cases
por: Pavlov, Ivan, et al.
Publicado: (2017)